Skip to content

Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage

Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03970681
Enrollment
40
Registered
2019-05-31
Start date
2019-05-29
Completion date
2020-05-31
Last updated
2019-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuroma, Acoustic

Keywords

Acoustic neuroma, Vestibular schwannoma, Spontaneous shrinkage, Neoplasm regression, Volume quantification, Tridimensional measurements, Volumetric measurements

Brief summary

To evaluate the regression characteristics of this Acoustic Neuroma population using volumetric data To study the relationship between regression and clinical characteristics including tinnitus, dizziness, hearing loss, and the intrinsic characteristics of the patients.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major subject (≥18 years old) * Subject followed in radiology for the assessment or follow-up of neuroma between January 01, 2013 and June 30, 2018 * Subject who has agreed to the use of his data for the purpose of this research * Subject presenting an untreated neuroma

Exclusion criteria

* Subject having expressed his opposition to participating in the study * Subject followed for neuroma of other cranial pairs, * Subject followed in the context of type II neurofibromatosis * Subject with a treated neuroma (radiotherapy or surgery)

Design outcomes

Primary

MeasureTime frame
Measurement of tumoral volume using tridimensional reconstruction on MRI, and kinetics of decayFiles analyzed from January 01, 2013 to June 30, 2018

Countries

France

Contacts

Primary ContactAnne CHARPIOT, MD, PhD
anne.charpiot@chru-strasbourg.fr33 3 88 12 76 49
Backup ContactGuillaume TRAU, MD
Guillaume.trau@chru-strasbourg.fr33 3 88 12 76 49

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026